Karl-Erik Andersson to Chemokine CXCL12
This is a "connection" page, showing publications Karl-Erik Andersson has written about Chemokine CXCL12.
Connection Strength
1.776
-
Bennington J, Williams JK, Andersson KE. New concepts in regenerative medicine approaches to the treatment of female stress urinary incontinence. Curr Opin Urol. 2019 07; 29(4):380-384.
Score: 0.602
-
Koudy Williams J, Dean A, Lankford S, Andersson KE. Efficacy and Initial Safety Profile of CXCL12 Treatment in a Rodent Model of Urinary Sphincter Deficiency. Stem Cells Transl Med. 2017 08; 6(8):1740-1746.
Score: 0.525
-
Williams JK, Dean A, Badra S, Lankford S, Poppante K, Badlani G, Andersson KE. Cell versus Chemokine Therapy in a Nonhuman Primate Model of Chronic Intrinsic Urinary Sphincter Deficiency. J Urol. 2016 12; 196(6):1809-1815.
Score: 0.486
-
Andersson KE, Williams JK. Regenerative pharmacology in urology. Investig Clin Urol. 2017 03; 58(2):79-81.
Score: 0.127
-
Zambon JP, Patel M, Hemal A, Badlani G, Andersson KE, Magalhaes RS, Lankford S, Dean A, Williams JK. Nonhuman primate model of persistent erectile and urinary dysfunction following radical prostatectomy: Feasibility of minimally invasive therapy. Neurourol Urodyn. 2018 09; 37(7):2141-2150.
Score: 0.035